ClinVar Miner

Submissions for variant NM_000212.2(ITGB3):c.433G>A (p.Asp145Asn) (rs121918445)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel,ClinGen RCV000851787 SCV001397522 likely pathogenic Glanzmann thrombasthenia 2020-09-08 reviewed by expert panel curation The NM_000212.2:c.433G>A variant that results in the Asp145Asn amino acid change is reported in two homozygous individuals in the literature (PMID: 31064749 and Proband NR in PMID: 9215749, Blood abstracts 1997 Suppl., & GT database). An additional homozygous patient has been identified through clinical testing. It is absent in population databases and is predicted damaging by in-silico tools. Asp145Tyr is a variant reported at the same residue and classified as likely pathogenic by the Platelet Disorders VCEP. In summary, based on the available evidence at this time, the Asp145Asn variant is classified as Likely Pathogenic. GT-specific criteria applied: PM2_supporting, PM3, PP3, PP4_moderate and PM5.
NIHR Bioresource Rare Diseases, University of Cambridge RCV000851787 SCV000899738 pathogenic Glanzmann thrombasthenia 2019-02-01 criteria provided, single submitter research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.